In a strategic move to enhance its health care and Food and Drug Administration practice, K&L Gates LLP has announced the addition of Mark Ogunsusi as a partner in its Washington, D.C. office. Ogunsusi, who previously held a position at Powers Pyles Sutter & Verville, brings a wealth of experience in regulatory matters pertaining to pharmacy law, pharmaceutical pricing, and value-based reimbursement arrangements.
Ogunsusi’s practice is centered around advising entities on health-care and drug pricing programs. His expertise includes navigating complex programs such as the Medicaid Drug Rebate Program, discounted pricing frameworks under the Nonprofit Institutions Act, and the 340B drug discount program. Additionally, he is well-versed in the Medicaid drug rebate program and Federal Supply Schedule pricing, areas that are increasingly significant given the current industry landscape and regulatory environment.
Ogunsusi’s arrival at K&L Gates adds considerable expertise to the firm’s offerings, especially in light of the evolving pharmaceutical and health care regulatory framework. This strategic hire is anticipated to further bolster the firm’s capacity to provide comprehensive legal guidance in these critical areas of law.
For further details, visit the Bloomberg Law article that covers this announcement extensively.